VITROS Intact PTH Reagent Pack recalled for negatively biased measurement results
Ortho-Clinical Diagnostics is recalling VITROS Intact PTH Reagent Packs due to negatively biased measurement results (average -12% shift). The affected reagent lots were distributed worldwide and may produce inaccurate patient test results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a diagnostic device producing systematically biased measurement results (average -12% negative shift). While no illnesses or injuries have been reported, the measurement inaccuracy poses a risk of diagnostic error affecting patient care decisions, fitting the rubric criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Ortho-Clinical Diagnostics, Inc. is recalling the VITROS Immunodiagnostic Products Intact PTH Reagent Pack (Catalog Number 6802892), a diagnostic reagent used to measure intact parathyroid hormone (iPTH) levels in serum and plasma samples. A total of 4,158 units have been affected and distributed worldwide to the United States and multiple international locations.
The recall was initiated due to negatively biased measurement results in the affected reagent lots. Laboratory and quality control testing revealed that patient iPTH results were systematically lower than expected, with an average -12% shift. This measurement inaccuracy could result in misinterpretation of patient test results and affect clinical decision-making.
The affected lot numbers are: 1610 (expires 24-Apr-2023), 1621 (expires 24-Apr-2023), 1630 (expires 08-May-2023), 1640 (expires 08-May-2023), 1645 (expires 08-May-2023), 1650 (expires 29-May-2023), and 1670 (expires 06-Jun-2023). The products carry UDI-DI 6802892 (10758750006267).
Laboratories and healthcare facilities using these reagent lots should discontinue use immediately and contact Ortho-Clinical Diagnostics for replacement reagents or further instructions. Review any test results obtained using the affected lots to ensure appropriate patient care.
The recalled product
- Product
- VITROS Immunodiagnostic Products Intact PTH Reagent Pack- IVD For the quantitative measurement of intact parathyroid hormone (iPTH) in human serum and plasma (EDTA or heparin) Catalog Number: 6802892
- Manufacturer
- Ortho-Clinical Diagnostics, Inc.
- Affected units
- 4,158
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- UDI-DI: 6802892 (10758750006267) Lot Numbers/Exp Date: 1610 24-Apr-2023
- 1621 24-Apr-2023
- 1630 08-May-2023
- 1640 08-May-2023
- 1645 08-May-2023
- 1650 29-May-2023
- 1670 06-Jun-2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Ortho-Clinical Diagnostics, Inc.
See all →- ModerateLactate slides in 18-slide cartridges recalled over calibration failures delaying results
FDA (Devices) · 2025-09-24
- ModerateLactate test slides recalled over calibration failures delaying patient results
FDA (Devices) · 2025-09-24
- ModerateCalcium test slides recalled after calibration failures delayed patient results
FDA (Devices) · 2025-08-27
- HighVITROS CHE slides can cause quality control drift with performance verifiers
FDA (Devices) · 2025-07-23
- HighVITROS CHE slides sold in Japan can cause quality control drift
FDA (Devices) · 2025-07-23
Same hazard · measurement bias
See all →- HighEmano Flow Uroflowmetry App Recalled Over Biased Flow Estimates
FDA (Devices) · 2026-07-29
- HighStago D-dimer assay shows positive bias across entire analytical range
FDA (Devices) · 2026-03-25
- HighCapillary tubes recalled over a positive bias in potassium results
FDA (Devices) · 2026-02-25
- HighVITROS Chemistry CRP Diagnostic Slides May Underreport Elevated Results
FDA (Devices) · 2024-12-04
- Highepoc BGEM BUN Test Cards recalled for sodium measurement bias
FDA (Devices) · 2024-11-13